Smartphone app helps the visually impaired ‘see’ — Aipoly

Aipoly, an app created by an American startup born out of the Singularity University in California, helps the blind, visually impaired and color blind recognize their surroundings via a smartphone. All users have to do is take a picture of an object in front of them, which is then analyzed and tagged by the app before being read back to them through text-to-speech technology. Alberto Rizzoli, Aipoly’s co-founder, explains how the app is letting people ‘see’ the world around them.


SU’s Emeline Paat-Dalhstrom Interview with Wamba

Today she is the chief impact officer for Singularity University. After that trip to the movies she made a conscious decision to study physics and aeronautical engineering, to lift her chances of being chosen for a space flight, and has worked for startups pioneering private space travel: Space Adventures which does spaceflights to the international space station, and Odyssey Moon which wants to send people to the moon again after landings were abandoned following the last one in 1972.



Twist Bioscience Corporation, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced the acquisition of Genome Compiler Corporation, an Israeli-based company providing software for genetic engineers, molecular and synthetic biologists. Twist Bioscience intends to leverage Genome Compiler’s technology and expertise to drive a digital products portfolio, including an eCommerce solution with gene design capabilities, expected to be available in the second half of 2016.


Singularity University — The Harvard of Silicon Valley | The Daily Beast

During a recent Executive Program at Silicon Valley’s Singularity University, the institution’s co-founder Peter Diamandis made some confident predictions.  Within the next decade, he said, self-driving cars will eliminate all driving fatalities. Artificial intelligence will soon surpass the skills of the best human doctors and remove all inefficiencies from health care systems. These AIs will invent new pharmaceuticals to cure previously fatal diseases and will 3D print customized medicines based on genetic analysis of individual patients. Perhaps best of all, he said, plummeting production costs and rising prosperity will make such fantastic medical care essentially free.